Publications
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial KU Leuven
Liraglutide vs. exenatide in combination with metformin and/or sulfonylurea therapy in type 2 diabetes mellitus therapy in Bulgaria: A modelling study KU Leuven
Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy Ghent University
Combination therapy for visceral leishmaniasis [comment] Institute of Tropical Medicine
The status of combination therapy for visceral leishmaniasis: an updated review Institute of Tropical Medicine
For the past 15 years, trials of combination therapy options for visceral leishmaniasis have been conducted with the aim of identifying effective, and safe treatment regimens that were shorter than existing monotherapy regimens and could also prevent or delay the emergence of drug resistance. Although first-line treatment currently relies on combination therapy in east Africa, this is not true in Latin America owing to disappointing trial ...
The optimal combination therapy for the treatment of early rheumatoid arthritis Vrije Universiteit Brussel KU Leuven
INTRODUCTION: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune condition traditionally viewed as a severe destructive disease affecting physical health and global wellbeing. The treatment strategies for RA have changed in the last decades from mainly symptomatic towards a more vigorous and targeted approach.
AREA COVERED: Reviewing recent literature enhanced by own expertise and research, a case is made for starting early ...